XEROX HOLDINGS CORPORATION
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.92B | $1.85B | $2.03B | $1.96B | $1.58B | $1.46B | $1.61B | $1.53B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $203.0M | $72.0M | — | — | $59.0M | $22.0M | — | — |
| Gross Margin | 10.6% | 3.9% | — | — | 3.7% | 1.5% | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $432.0M | $430.0M | $431.0M | $477.0M | $368.0M | $378.0M | $377.0M | $370.0M |
| Operating Income | $31.0M | $-73.0M | — | $-300.0M | $-60.0M | $-67.0M | — | $-1.09B |
| Operating Margin | 1.6% | -4.0% | — | -15.3% | -3.8% | -4.6% | — | -71.1% |
| Interest Expense | $118.0M | $103.0M | $100.0M | $101.0M | $78.0M | $55.0M | $55.0M | $57.0M |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | $18.0M | $32.0M | $12.0M | $460.0M | $46.0M | $23.0M | $17.0M | $118.0M |
| Net Income | $13.0M | $-105.0M | $-73.0M | $-760.0M | $-106.0M | $-90.0M | $-21.0M | $-1.21B |
| Net Margin | 0.7% | -5.7% | -3.6% | -38.8% | -6.7% | -6.2% | -1.3% | -78.9% |
| EPS (Basic) | $0.07 | $-0.84 | $-0.62 | $-6.01 | $-0.87 | $-0.75 | $-0.22 | $-9.71 |
| EPS (Diluted) | $0.07 | $-0.84 | $-0.62 | $-6.01 | $-0.87 | $-0.75 | $-0.21 | $-9.71 |
| Shares Outstanding (Basic) | 130.9M | 129.0M | 126.5M | 126.9M | 125.8M | 125.2M | 124.2M | 124.3M |
| Shares Outstanding (Diluted) | 130.9M | 129.0M | 126.5M | 126.9M | 125.8M | 125.2M | 124.2M | 124.3M |
| Dividends Per Share | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.13 | $0.25 | $0.25 |